Speaker Group: Speaker 2022

Dr Garrett McGovern

Dr McGovern qualified in Medicine in 1995 from Trinity College Dublin and has worked as a GP specialising in the treatment of substance misuse since the implementation of the methadone treatment protocol in 1998. He is Medical Director of the Priority Medical Clinic, a private addiction treatment programme located in South County Dublin. In January… Read more »

Stefaan Hendrickx

Stefaan Hendrickx is a sociologist (University of Leuven) and has been working on tobacco for the Flemish Institute for Healthy Living for 12 years. Within the organization he is responsible for the substantive coordination of the theme, development of methodologies, advice for the Flemish government, development of projects with a new focus such as tobacco-related… Read more »

David Graham

David Graham is Chief Impact Officer at NJOY, a role which leads efforts across the company to maximize the positive impact on public health of the company’s products and services through increasing their reach and effectiveness while including oversight of regulatory affairs for the company. He has extensive experience in nicotine and non-nicotine new product… Read more »

Liam Humberstone

Liam is a technologist, engineer and scientist committed to the ongoing development of the e-cigarette, e-liquids and vaping in the interest of providing a continuously improving alternative to combustible tobacco. He was steering group member for one of the first recognised standards concerning e-cigarettes, BSI PAS 54115:2015. Since then, he has been active in European… Read more »

Prof Maciej L. Goniewicz

Dr. Maciej L. Goniewicz joined the staff of Roswell Park Comprehensive Cancer Center (Roswell Park) in 2013 as Assistant Member of the Department of Health Behavior, Division of Cancer Prevention and Population Sciences. In 2016, he was appointed Associate Member and as a Full Member in 2021. He is a Director of the Nicotine and… Read more »

Prof Geoffrey T. Fong, OC, Ph.D., FRSC, FCAHS

Dr. Fong is Professor of Psychology and Public Health Sciences at the University of Waterloo and Senior Investigator at the Ontario Institute for Cancer Research. Dr. Fong is Founder and Chief Principal Investigator of the International Tobacco Control Policy Evaluation Project (the ITC Project), a large international consortium of 150 researchers across 31 countries, covering… Read more »

Associate Prof Sivakumar Thurairajasingam

Associate Professor Sivakumar A/L Thurairajasingam is Associate Professor (Practice) in Psychiatry and Deputy Head (Education) of the Clinical School Johor Bahru. Dr Sivakumar joined Monash University Malaysia on 1st August 2006 as a lecturer. He obtained his MBBS from the University of Mangalore, India (1994) and then went on to complete his Master in Medicine… Read more »

Mitch Zeller, J.D

Mitch Zeller, J.D., was the director of the FDA’s Center for Tobacco Products from March 2013 through April 2022. The mission of CTP—established by enactment of the 2009 Family Smoking Prevention and Tobacco Control Act—is “to make tobacco-related death and disease part of America’s past, not America’s future, and, by doing so, ensure a healthier… Read more »

Dr Jasmine Khouja

Jasmine Khouja is a Senior Research Associate in smoking studies at the University of Bristol. Her work focuses on the causes and consequences of e-cigarette use as well as the potential impact that e-cigarette policy changes could have on adult smokers, adult vapers and young people. Using a range of methods (including novel methods in… Read more »

Rosanna O’Connor

Rosanna O’Connor has been appointed as the Director of Addictions & Inclusion in the new Office of Health Improvement & Disparities, following her interim role as director of Public Health England’s (PHE) Health Improvement Directorate, during the pandemic and PHE’s Transition. Rosanna’s new role covers alcohol, drugs, tobacco, and gambling, plus the inclusion health agendas… Read more »